Search

Neuromod Devices’ €30m funding powers Lenire expansion

Neuromod Devices, the global technology business behind scientifically proven tinnitus treatment technology, Lenire, closed €30m funding to expand availability of the groundbreaking tinnitus intervention.

Get 20% off your ticket to the Tinnitus Conference 2023

Join Tinnitus UK for their fourth virtual Tinnitus Conference with 20 sessions presenting the latest information and research from world leaders at the forefront of tinnitus and tinnitus support.

Interacoustics introduces a new diagnostic test at EUHA

Interacoustics is happy to introduce the Audible Contrast Threshold (ACT™) test; a new, diagnostic test to support the number one challenge with hearing loss: difficulty hearing speech in background noise.

A triple threat: showcasing Peptest at three ENT conferences

BIOHIT HealthCare is thrilled to be attending three prestigious otorhinolaryngology conferences over the next few weeks.

UV Smart D60: sustainability in every disinfection cycle

The UV Smart D60 is a CE marked (MDR Class IIa) disinfection device specifically designed for channel-less ENT endoscopes and TEE probes.

HIMSA Rings in the New Year with Lower Noah ES Prices!

HIMSA is happy to announce that due to a successful 2023, we are now able to offer significant price reductions on a Noah ES yearly subscription.

Peptest™ takes centre stage: join BIOHIT HealthCare at the top UK ENT meetings in 2024

BIOHIT HealthCare is excited to be attending several of the most prestigious ENT meetings across the UK in 2024.

Information for vestibular professionals and patients

The Ménière’s Society is a registered charity dedicated solely to supporting people affected by vestibular disorders.

C2Dx acquires otolaryngology/head and neck surgery products from Cook Medical

C2Dx Inc., a medical device company based in the U.S., has acquired the otolaryngology/head and neck surgery (“OHNS”) family of products from Cook Medical.

Carleton Medical Ltd, continuation of Lumenis CO2 support

In line with the announcement from Boston Scientific informing customers that they will cease global production of the Lumenis range of CO2 lasers at the end of 2024, Carleton Medical Ltd wish to reassure continuation of service.

High praise for Peptest®: diagnosing LPR with confidence

BIOHIT HealthCare recently filmed an exciting testimonial video with Jane Shaw, Consultant Speech and Language Therapist (SLT) at Doncaster and Bassetlaw Hospitals NHS Trust.

UK innovation aims to end Otic Barotrauma for sufferers

In a groundbreaking development, AirDrate®, a UK start-up, has unveiled a revolutionary solution to help alleviate the agony of Airplane Ear